No Imagination | GenomeWeb

No Imagination

Is innovation becoming a lost art in the pharmaceutical industry? A new survey of 282 pharmaceutical executives, done at the behest of clinical research organization Quintiles, found that 54 percent consider innovation to be a leading priority and 49 percent rank their overall innovation strategy as, at best, moderately effective, says Pharmalot's Ed Silverman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.